Loading organizations...
§ Private Profile · Suzhou, Jiangsu, China
CDMO specializing in Cell and Gene Therapy with end-to-end services.
Porton Advanced Solutions has raised $80.0M across 1 funding round.
Porton Advanced Solutions has raised $80.0M in total across 1 funding round.
Porton Advanced Solutions has raised $80.0M across 1 funding round. Most recently, it raised $80.0M Series B in August 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 22, 2022 | $80M Series B | China Merchants Capital, Merchant Health | CS Capital, Fosun Health Capital, Gortune Investment, HM Capital, Momentum Ventures, Porton Pharma Solutions, Ruilian Xingshan Capital, Sdictk | Announced |
Porton Advanced Solutions has raised $80.0M in total across 1 funding round.
Porton Advanced Solutions's investors include China Merchants Capital, Merchant Health, CS Capital, Fosun Health Capital, Gortune Investment, HM Capital, Momentum Ventures, Porton Pharma Solutions, Ruilian Xingshan Capital, SDICTK.